Natco Pharma Ltd.

Financial

	Natco Pharma	Orchid Pharma	Jubilant Pharmova
Operational Metrics
API Sector
US DMF Filings	55.0 .	n/a	98.0 .
Pharmaceutical Sector
Number of ANDA's Filed in USA	51.0 .	n/a	100.0 .
Number of ANDA's Approved By USFDA	41.0 .	n/a	62.0 .
Domestic Sales Growth - YoY	31.2 %	n/a	n/a
R&D as a % of Total Sales	8.0 %	n/a	0.61 %
Financials
5 yr Average ROE	12.01 %	-7.68 %	10.45 %
5yr average Equity Multiplier	1.19	0.59	2.05
5yr Average Asset Turnover Ratio	0.44	0.38	0.64
5yr Avg Net Profit Margin	22.3 %	-6.96 %	8.17 %
Price to Book	3.33	4.73	2.05
P/E	13.8	44.46	293.57
5yr Avg Cash Conversion Cycle	55.67 Days	49.91 Days	-3.54 Days
Inventory Days	103.24 Days	112.74 Days	78.49 Days
Days Receivable	93.53 Days	105.72 Days	54.89 Days
Days Payable	180.2 Days	255.1 Days	167.25 Days
5yr Average Interest Coverage Ratio	37.72	0.47	4.68
5yr Avg ROCE	15.05 %	-4.58 %	10.85 %
5yr Avg Operating Profit Margin	34.37 %	10.74 %	20.24 %
5 yr average Debt to Equity	0.07	-0.45	0.71
5yr CAGR Net Profit	2.11 %	-7.77 %	n/a
5yr Average Return on Assets	10.04 %	-2.51 %	5.11 %
Shareholdings
Promoter Holding	49.71 %	69.84 %	50.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.84 %	-28.23 %	0.0
Change in Mutual Fund Holding (3 Yrs)	-5.37 %	15.18 %	1.49 %

Business

	Natco Pharma	Orchid Pharma	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Formulations 88.61 Active Pharmaceutical Ingredient (API) 5.82 Crop Protection 1.77 Sterile 0 Oral Formulations 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Others 3.8	Product Wise Break-Up 0 Solid dosage formulations 0 Formulations 0 India Branded pharmaceuticals 0 Oral Formulations 68.28 Active Pharmaceutical Ingredient (API) 0 Active pharmaceutical ingredients 0 Sterile 31.72 Life science chemicals 0 Specialty intermediates 0 0 Allergy therapy products 0 Crop Protection 0 Nutritional products 0 Radiopharmaceuticals 0	Product Wise Break-Up Contract Manufacturing 18.57 Solid dosage formulations 11.58 Formulations 0 India branded pharmaceuticals 0.57 Oral Formulations 0 Active Pharmaceutical Ingredient (API) 0 Active Pharmaceutical Ingredient (API) 10.08 Sterile 0 Life science chemicals 0 Specialty intermediates 0 Contract Research and Development Services 8.37 Anti-allergic 9.69 Crop Protection 0 Nutritional products 0 Radiopharmaceuticals 40.74 Others 0.4
Segment Break-Up	Segment Break-Up Pharmaceuticals 98.14 Agrochemicals 1.86 CDMO Sterile Injectables 0 Generics 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 0 Life Science Ingredients 0	-	Segment Break-Up Pharmaceuticals 0 CDMO Sterile Injectables 18.47 Allergy Immunotherapy 10.13 Radiopharma 44.22 Generics 11.69 Agrochemicals 0 Life Science Ingredients 0 Proprietary Novel Drugs 0 Drug discovery and development solutions 15.49
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Oncology 58.79 Others 41.21	-	-
Location Wise Break-Up	Location Wise Break-Up USA 59.55 Rest of the World 22.23 India 18.22 China 0 Americas and Europe 0	Location Wise Break-Up China 0 Rest of the World 0 India 15.85 Americas and Europe 0 USA 0 Others 84.15	Location Wise Break-Up China 0 Rest of the World 8.0 India 2.39 Americas and Europe 89.61 USA 0
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceuticals 100.0 Agrochemicals 0 Generics 0 CDMO Sterile Injectables 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0	-	Operating Profit Break-Up Pharmaceuticals 0 CDMO Sterile Injectables 7.13 Allergy Immunotherapy 24.76 Radiopharma 58.92 Generics 0 Agrochemicals 0 Life Science Ingredients 0 Proprietary Novel Drugs 0 Contract Research and Development 9.18 Others 0.01
Asset Break-Up	Asset Break-Up Pharmaceuticals 92.85 Agrochemicals 7.15 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0	-	Asset Break-Up Pharmaceuticals 0 Agrochemicals 0 Life Science Ingredients 0 Proprietary Novel Drugs 2.02 Contract Research and Development 14.18 Others 83.8

Natco Pharma Ltd.

SIGN UP FOR FREE